Splenectomy clinical trials

Explore recruiting splenectomy clinical trials.

Recruiting splenectomy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Splenectomy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immunogenicity and safety of a meningococcal serogroup B vaccine in adult patients with asplenia

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

(BIPAS) A prospective trial to assess Pneumococcal vaccine B cell response in patients without a spleen: a controlled study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A 60 month, single-arm, proof-of-concept study to induce allogeneic tolerance in deceased donor liver transplant recipients using siplizumab, an anti-CD2 antibody in combination with cyclophosphamide and splenectomy.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KER-050 as Monotherapy or in Combination with Ruxolitinib in Participants with Myelofibrosis.

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Splenectomy trials by city

Splenectomy in Toronto Splenectomy in Vancouver Splenectomy in Montreal Splenectomy in Calgary Splenectomy in Edmonton Splenectomy in Ottawa Splenectomy in Winnipeg Splenectomy in Quebec City Splenectomy in Hamilton Splenectomy in Kitchener Splenectomy in London Splenectomy in Halifax Splenectomy in New York Splenectomy in Los Angeles Splenectomy in Chicago Splenectomy in Houston

Splenectomy clinical trials

Recruiting splenectomy studies right now

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients

Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

Stanford Program to Accelerate Robotic Children's Surgery

A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension

Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection

Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.

The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

Meningococcal B Vaccine in Patients with Asplenia

Also recruiting in Europe

Immunogenicity and safety of a meningococcal serogroup B vaccine in adult patients with asplenia

(BIPAS) A prospective trial to assess Pneumococcal vaccine B cell response in patients without a spleen: a controlled study.

A 60 month, single-arm, proof-of-concept study to induce allogeneic tolerance in deceased donor liver transplant recipients using siplizumab, an anti-CD2 antibody in combination with cyclophosphamide and splenectomy.

A Phase 2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KER-050 as Monotherapy or in Combination with Ruxolitinib in Participants with Myelofibrosis.

Splenectomy trials by city

Other conditions